Finance Home - My Yahoo - Yahoo! - Help

Monday, November 30, 2009, 12:13PM ET - U.S. Markets close in 3 hours and 47 minutes. Dow  0.27% Nasdaq  0.62%

Orexigen Therapeutics, Inc. (OREX)

At 11:58AM ET: 6.77   0.13 (1.88%)

MORE ON OREX

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Sat, Nov 28, 2009 • 12 Years Of Patent Protection For Biologics Based Research And Development Creates Buying Opportunity In Biotech Stocks Wall Street Transcript (Sat, Nov 28) Thu, Nov 26, 2009 • Insider Buying Bodes Well For Orexigen at Seeking Alpha (Thu, Nov 26) Wed, Nov 25, 2009 • Founder Scott Cook Sells $14.7M Worth of Intuit TheStreet.com (Wed, Nov 25) Tue, Nov 24, 2009 • OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E EDGAR Online (Tue, Nov 24) • Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (Tue, Nov 24) Mon, Nov 23, 2009 • The Side Effect of Developing Obesity Drugs at Motley Fool (Mon, Nov 23) • Poniard Finds Cash to Keep Lights On: BioBuzz at TheStreet.com (Mon, Nov 23) • Cel-Sci Chairman Sells Stock, Despite Sweetheart Loan Deal: BioBuzz at TheStreet.com (Mon, Nov 23) • FDA Issues New Obesity Drug Heart Warning: BioBuzz at TheStreet.com (Mon, Nov 23) • Four Senior Executives Join Orexigen(R) Therapeutics Management Team PR Newswire (Mon, Nov 23) Wed, Nov 18, 2009 • Obesity and ED: Two Big Markets, One Tiny Company at Minyanville.com (Wed, Nov 18) • Vivus shares rise on positive avanafil study data AP (Wed, Nov 18) Mon, Nov 16, 2009 • Merck's Dick Clark Has Opportunities, but All Are Risky at The Wall Street Journal Online (Mon, Nov 16) Thu, Nov 12, 2009 • Orexigen(R) Therapeutics to Speak at Lazard Capital Markets Healthcare Conference PR Newswire (Thu, Nov 12) Wed, Nov 11, 2009 • OREXIGEN THERAPEUTICS, INC. Financials EDGAR Online Financials (Wed, Nov 11) Thu, Nov 5, 2009 • OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online (Thu, Nov 5) • Orexigen 3rd-quarter loss narrows on lower costs AP (Thu, Nov 5) • New Star Analyst Rankings for Orexigen Therapeutics, Inc. StarMine (Thu, Nov 5) Wed, Nov 4, 2009 • Orexigen Therapeutics, Inc. Earnings Call scheduled for 5:00 pm ET today CCBN (Wed, Nov 4) • OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or EDGAR Online (Wed, Nov 4) Older Headlines - Download Recent Headlines View headlines from: Wed, Nov 4, 2009Wed, Oct 28, 2009Wed, Oct 21, 2009Wed, Oct 14, 2009Wed, Oct 7, 2009Wed, Sep 30, 2009Wed, Sep 23, 2009Wed, Sep 16, 2009Wed, Sep 9, 2009Wed, Sep 2, 2009 Add OREX News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage